Nonalcoholic fatty liver disease: A frequent condition in type 2 diabetic patients

Wiener Klinische Wochenschrift

Volumn 126, Issue 11-12, 2014, Pages 335-340

  Sima, Alexandra ^a   Timar, Romulus ^a   Vlad, Adrian ^a   Timar, Bogdan ^a   Rosu, Mihaela ^a   Dan, Isabel ^a   Sirli, Roxana ^a   Popescu, Alina ^a   Sporea, Ioan ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Fatty liver; Obesity; Type 2 diabetes mellitus; Ultrasound

Indexed keywords

ALANINE AMINOTRANSFERASE; HEMOGLOBIN A1C; TRIACYLGLYCEROL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; BODY MASS; DIABETIC PATIENT; ECHOGRAPHY; FATTY LIVER; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTRANSAMINASEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PHYSICAL EXAMINATION; PROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL; ADOLESCENT; AGE DISTRIBUTION; COMORBIDITY; DIABETES MELLITUS, TYPE 2; HYPERLIPIDEMIAS; NON-ALCOHOLIC FATTY LIVER DISEASE; PREVALENCE; RISK FACTOR; ROMANIA; SEX RATIO; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PREVALENCE; RISK FACTORS; ROMANIA; SEX DISTRIBUTION; YOUNG ADULT;

EID: 84903704067     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-014-0530-8     Document Type: Article

References (21)

1. Mavrogiannaki AN, Migdalis IN. Nonalcoholic fatty liver disease, diabetes mellitus and cardiovascular disease: newer data. Int J Endocrinol. 2013;2013:450639.
2. World Gastroenterology Organisation Global Guidelines. Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. World Gastroenterology Organisation; 2012.
3. Hùlek P, Dresslerová I. Steatosis and steatohepatitis in diabetic patient. Vnitr Lek. 2011;57:364-7.
4. Lomonaco R, Chen J, Cusi K. An endocrine perspective of nonalcoholic fatty liver disease (NAFLD). Ther Adv Endocrinol Metab. 2011;2:211-25.
5. Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124-31.
6. Caldwell S. Cryptogenic cirrhosis: what are we missing? Curr Gastroenterol Rep. 2010;12:40-8. Review.
7. Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology. 2010;51:1820-32.
8. Bellentani S, Marino M. Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Ann Hepatol. 2009;8(Suppl.):S4-8.
9. Lomonaco R, Sunny NE, Bril F, Cusi K. Nonalcoholic fatty liver disease: current issues and novel treatment approaches. Drugs. 2013;73:1-14.
10. Younossi ZM, Stepanova M, Afendy M, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011;9:524-30.
11. Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006;40(Suppl. 1):S5-10.
12. Ong JP, Elariny H, Collantes R, et al. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg. 2005;15:310-5. (Pubitemid 40463594)
13. Prashanth M, Ganesh HK, Vima MV, et al. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. J Assoc Physicians India. 2009;57:205-10.
14. Doycheva I, Patel N, Peterson M, Loomba R. Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes. J Diabetes Complications. 2013;27:293-300.
15. Smith BW, Adams LA. Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nat Rev Endocrinol. 2011;7:456-65.
16. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142:1592-609.
17. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34:274-85.
18. Leite NC, Salles GF, Araujo AL, et al. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int. 2009;29:113-9.
19. Palmentieri B, de Sio I, La Mura V, et al. The role of liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis. 2006;38:485-9. (Pubitemid 44356237)
20. Mathiesen UL, Franzen LE, Aselius H, et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis. 2002;34:516-22. (Pubitemid 34830694)
21. Sporea I, Şirli R, Başa E, et al. The value of transabdominal ultrasound for assessment of the severity of liver steatosis as compared to liver biopsy. Cent Eur J Med. 2009;4:490-5.